About Kestra Medical Technologies
Kestra Medical Technologies is a publicly listed company based in Kirkland (United States) founded in 2014. Medical devices are developed to support cardiovascular patients at risk. Kestra Medical Technologies has raised $196 million across 2 funding rounds from investors including Bain Capital, T. Rowe Price and Andera Partners. The company has 330 employees. Its chief executive, as recorded, is Brian Webster. Kestra Medical Technologies offers products and services including ASSURE System, Kestra CareStation, and ASSURE Patient Application. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Kestra Medical Technologies, Inc. Its competitors include AtaCor Medical, CardioFocus and AtriCure; 2 of its 3 listed competitors have raised funding.
Company details
Kestra Medical Technologies was founded in 2014 and is based in Kirkland, United States. Operations center on the medical technology sector, where external defibrillation systems, implantable cardiac rhythm management devices, and class III medical devices are developed to aid patients vulnerable to cardiovascular conditions. Collaborations are pursued with entities specializing in consumer wearables, wireless solutions, and therapeutic class III devices.
- Headquarters Kirkland, United States
- Employees 330
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website kestramedical.com
- Social LinkedIn X Facebook
- Legal Name Kestra Medical Technologies, Ltd.
- Annual Revenue$95.13 M (USD)59.03as on Apr 30, 2026
- Net Profit-$131.61 M (USD)-15.64as on Apr 30, 2026
- EBITDA-$126.03 M (USD)-28.07as on Apr 30, 2026
- Total Equity Funding$196M (USD)
in 2 rounds
- Latest Funding Round$196M (USD), Series B
Jul 2024
- InvestorsBain Capital
& 9 more
- Employee Count330
Products & Services of Kestra Medical Technologies
Kestra Medical Technologies offers a comprehensive portfolio of products and services, including ASSURE System, Kestra CareStation, and ASSURE Patient Application.
Wearable defibrillator for monitoring and treating cardiac arrhythmias.
Platform for managing at-risk cardiac patient data remotely.
App to engage patients in their cardiac recovery and monitoring.
Apps and channels of Kestra Medical Technologies
Kestra Medical Technologies publishes 1 mobile app with over 1K+ downloads.
Funding Insights of Kestra Medical Technologies
Kestra Medical Technologies has successfully raised a total of $196M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $196 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $196M
- Total Rounds 2
- Last Round Series B — $196M
- Investors Count 10
All 2 funding rounds of Kestra Medical Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2024 | $196M | Series B | – | Andera Partners, Ally Bridge Group | |
| Jun 2014 | Series A | – | Bain Capital Life Sciences | – |
10 investors in total: 10 institutional.
Investors in Kestra Medical Technologies
Kestra Medical Technologies has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Bain Capital, T. Rowe Price and Andera Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Capital is provided to firms for growth, buyouts, and acquisitions. | 2001 | anderapartners.com | Paris, France | |
Private equity and hedge fund investments in healthcare are managed. | ally-bridge.com | Hong Kong, China | ||
Private equity firm focused on life science sector | longitudecapital.com | Menlo Park, United States | ||
Venture capital firm | omegafunds.com | Boston, United States | ||
Eventide is engaged in values-based investment management services. | 2008 | eventideinvestments.com | Boston, United States | |
Debt and equity investments are pursued across multiple sectors. | 1984 | baincapital.com | Boston, United States | |
Endeavour Vision is focused on transformative healthcare technology investments. | endeavourvision.com | Geneva, Switzerland | ||
Investments are focused on pharmaceutical, biotechnology, and medical sectors. | baincapitallifesciences.com | Boston, United States | ||
Diversified asset management services are provided to investors globally. | 1937 | troweprice.com | Baltimore, United States | |
Investment services are provided to healthcare technology innovators by Gilmartin Capital. | gilmartincap.com | San Francisco, United States |
Investor details for Kestra Medical Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Kestra Medical Technologies
36 people are tracked at Kestra Medical Technologies (16 in leadership, 5 in board & advisors, 15 in team); the tracked headcount is 330.
| Name | Role | Group |
|---|---|---|
Brian Webster | CEO | Leadership |
Laura Gustavson | VP, Clinical Marketing | Leadership |
Tim Moran | Chief Business Officer | Leadership |
Al Ford | Chief Commercial Officer (cco) | Leadership |
Jennifer Imerini | Director OF Field Service Operations | Leadership |
Beverly Magrane | VP, Quality & Regulatory Affairs | Leadership |
Traci Umberger | General Counsel & Chief Administrative Officer | Leadership |
Vaseem Mahboob | Chief Financial Officer | Leadership |
Keith Claeys | VP, Finance | Leadership |
Jeff Laub | VP, Operations & Supply Chain | Leadership |
Kirk Shaffer | Director Customer Order And Billing | Leadership |
Simpson Kwan | VP, Financial Planning & Analysis | Leadership |
Phillip Foshee | VP, Research & Development | Leadership |
Vince Bertolini | Regional Sales Director | Leadership |
Rhiannon Pickus | Director Of Marketing And Communications | Leadership |
Gordon Teddy | VP, IT & Customer Experience | Leadership |
Robert Barmann | Director | Board & advisors |
Mary Kay Ladone | Director | Board & advisors |
Orly Mishan | Director | Board & advisors |
Nicholas Downing | Director | Board & advisors |
16 more people are available in the full profile.
Complete people profiles for Kestra Medical Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Kestra Medical Technologies
Kestra Medical Technologies is a publicly listed company on the NASDAQ with ticker symbol KMTS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date06 Mar 2025
- Listed onNASDAQ: KMTS
- Listed entityKestra Medical Technologies, Ltd.
- Exchange sectorHealth technology
- ISINBMG524411052
- Share price$26.97 (+0.22% on the day) · 2026-10-13
- Market capitalisation$1.61B
- EPS (diluted, trailing year)$-2.67
- Volume (last session)131,143
Financials of Kestra Medical Technologies
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $95.1M | -$131.6M | -$126.0M |
| 2024 | $59.8M | -$113.8M | -$98.4M |
| 2023 | $27.8M | -$94.1M | -$73.5M |
| 2022 | $7.6M | -$84.2M | -$75.6M |
Detailed financial statements for Kestra Medical Technologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Kestra Medical Technologies
4 dated milestones of Kestra Medical Technologies across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Kestra Medical Technologies is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $196.0M.
- IPO Lists on the stock exchange (IPO).
Competitors of Kestra Medical Technologies
Kestra Medical Technologies has 3 listed competitors in our database, 2 of them funded. They include AtaCor Medical, CardioFocus and AtriCure.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| atacor.com | 2014 | San Clemente, United States | $136.8M | 15 | An implantable pacemaker system is developed for cardiac pacing therapy. | |
| cardiofocus.com | 1990 | Marlborough, United States | $260.86M | 105 | Endoscopic catheter for atrial fibrillation ablation is developed. | |
| atricure.com | 2000 | Mason, United States | 1,874 | Cardiac ablation and occlusion devices for atrial fibrillation are provided. |
Detailed competitors of Kestra Medical Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Kestra Medical Technologies
The website of Kestra Medical Technologies (kestramedical.com) receives about 9.1K visits a month.
- Monthly visits9.1K
▲ 33.8% vs previous month
Websites whose visitors overlap most with Kestra Medical Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| tactileinc.com | 100% | #4,089,437 | View details | ||
| kestrafinancial.com | 100% | 93.5K | #367,729 | View details |
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Kestra Medical Technologies (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kestra Medical Technologies
Complete news archive for Kestra Medical Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kestra Medical Technologies
Kestra Medical Technologies was founded in 2014.
Kestra Medical Technologies is headquartered in Kirkland, United States. It is registered at Kirkland, Washington, United States.
Brian Webster is the CEO of Kestra Medical Technologies, as recorded in our data.
Kestra Medical Technologies is a funded company, having raised a total of $196M across 2 funding rounds to date.
Kestra Medical Technologies has 330 employees.
Annual revenue of Kestra Medical Technologies is $95.13M as on Apr 30, 2026.
Kestra Medical Technologies was founded in 2014 and is based in Kirkland, United States. Operations center on the medical technology sector, where external defibrillation systems, implantable cardiac rhythm management devices, and class III medical devices are developed to aid patients vulnerable to cardiovascular conditions. Collaborations are pursued with entities specializing in consumer wearables, wireless solutions, and therapeutic class III devices.
Kestra Medical Technologies's top competitors include AtaCor Medical, AtriCure and CardioFocus.
Kestra Medical Technologies offers ASSURE System, Kestra CareStation, and ASSURE Patient Application.
Yes, Kestra Medical Technologies is publicly traded on NASDAQ under the ticker symbol KMTS.
Kestra Medical Technologies has 10 investors. Key investors include Bain Capital, T. Rowe Price, Andera Partners, Ally Bridge Group, and Longitude Capital.
Kestra Medical Technologies operates through Kestra Medical Technologies, Inc..